We believe that everyone deserves a colourful retirement and, in some ways, we’re already part way there. In the UK life expectancy has seen a sustained, improved trajectory, rising year on year. People are living longer – but are they living better?
At Legal & General, we’re following on from our investment in the Advanced Care Research Centre, to understand how we age, by investing in healthy ageing. We’re focusing on innovations aimed at improving health expectancy, tying in with the Government’s ‘healthy ageing’ strand of its Industrial Strategy Challenge Fund. Mostly using our own balance sheet, as well as a £6 million grant we won from Innovate UK, we’re investing in preventative-focused early-stage start-ups that use technology to improve ‘health expectancy’ by preventing, diagnosing or treating common conditions that affect quality of life, giving the people at the heart of our society the later life they deserve. By investing in these types of solutions, we can lessen the burden on the NHS and empower individuals to take control of their health as they age. Our two current portfolio companies are Current Health and Congenica.
We have set out four core areas of priority that will shape our investment, based on the biggest health risks: illnesses and conditions that are also mitigatable and, in some cases, preventable.